-
Fmoc-3-(2-naftyl)-L-alanine 112883-43-9
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Amino acid rige |Fmoc-3-(2-naftyl)-L-alanine |CAS:112883-43-9 |C28H23NO4
-
Fmoc-Trp(Boc)-OH 143824-78-6
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Fmoc-Trp(Boc)-OH |CAS:143824-78-6 |C31H30N2O6
-
Fmoc-L-Leucine 35661-60-0
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Amino acid rige |Fmoc-L-Leucine |CAS: 35661-60-0 |C21H23NO4
-
Fmoc-D-leucine 114360-54-2
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Amino acid rige |Fmoc-D-leucine |CAS: 114360-54-2 |C21H23NO4
-
![N6-[(1,1-Dimethylethoxy)karbonyl]-N2-[(9H-fluoren-9-ylmethoxy)karbonyl]-2-methyl-L-lysine 1202003-49-3](https://www.yisunbio.com/uploads/281.jpg)
N6-[(1,1-Dimethylethoxy)karbonyl]-N2-[(9H-fluoren-9-ylmethoxy)karbonyl]-2-methyl-L-lysine 1202003-49-3
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine |CAS:1202003-49-3 |C27H34N2O6
-
![O-[2-[[(1,1-Dimethylethoxy)karbonyl]amino]etyl]-N-[(9H-fluoren-9-ylmethoxy)karbonyl]-L-tyrosine 1013883-02-7](https://www.yisunbio.com/uploads/29-300x115.jpg)
O-[2-[[(1,1-Dimethylethoxy)karbonyl]amino]etyl]-N-[(9H-fluoren-9-ylmethoxy)karbonyl]-L-tyrosine 1013883-02-7
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |O-[2-[[(1,1-Dimethylethoxy)karbonyl]amino]etyl]-N-[(9H-fluoren-9-ylmethoxy)karbonyl]-L-tyrosine |CAS:1013883-02-7 |C31H34N2O7
-
Hippuric acid 495-69-2
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Hippuric acid |CAS:495-69-2 |C9H9NO3
-
Valsartan 137862-53-4
Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Hypertensie behanneling |Valsartan Intermediates |Valsartan |CAS:137862-53-4 |C24H29N5O3
-
L-Valine methylester hydrochloride 6306-52-1
Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Valsartan Intermediates |L-Valine methylester hydrochloride |CAS: 6306-52-1 |C6H13NO2.HCl
-
![N-[(2'-cyano[1,1'-bifenyl]-4-yl)methyl]-L-valine methylester hydrochloride 482577-59-3](https://www.yisunbio.com/uploads/34.jpg)
N-[(2'-cyano[1,1'-bifenyl]-4-yl)methyl]-L-valine methylester hydrochloride 482577-59-3
Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Hypertensie behanneling |Valsartan Intermediates |N-[(2'-Cyano[1,1'-bifenyl]-4-yl)methyl]-L-valinemethylesterhydrochloride |CAS: 482577-59-3 |C20H22N2O2.HCl
-
Valsartan methylester 137863-17-3
Profesjonele manufacturing en oanbod biopharmaceutical |Chemical Reagents |Gemyske grûnstoffen |Yndustriële farmaseutyske tuskenlizzende |Cardiovascular |Hypertensie behanneling |Valsartan Intermediates |N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-bifenyl]-4-yl]methyl]-L-valinemethylester |CAS:137863-17-3 |C25H31N5O3
-
(S)-2,4-Dichloro-alfa-(chloromethyl)-benzeenmethanol 126534-31-4
Profesjonele manufacturing en oanbod biopharmaceutical |Pharmaceutical Intermediates Reagents |Ynfeksjesykten |Dermatologysk |Luliconazole Intermediates |(S)-2,4-Dichloro-alfa-(chloromethyl)-benzenemethano |CAS:126534-31-4 |C8H7Cl3O